Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

A fruit-fly study links glial Fos activity to inflammation and motor decline in an ALS model

Original source

Fos regulates age-dependent neuroinflammation in a VAPP58S model of amyotrophic lateral sclerosis.Dis Model Mech · 24 July 2026 (opens in a new tab)

Compass summarised this from the study's abstract.

Study details

Studied in
Human, Animal

Researchers created a fruit-fly model carrying the ALS-linked VAPB P58S mutation. In the flies, inflammation increased with age in brain glial cells, while increasing activity of the Fos equivalent Kayak in those cells reduced inflammation and improved motor function. Reducing Kayak had the opposite effects.

Why this matters

The findings point to glial-cell inflammation and Fos-related signalling as possible mechanisms involved in disease progression. This was an experiment in fruit flies, so it does not change treatment for people with ALS and does not show that targeting Fos will help patients.

Limitations and context

The study used genetically engineered fruit flies, not people. Its findings need to be tested in mammalian models and human disease before their relevance to ALS treatment can be assessed.

Summarised by Compass 9 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Bibliographic data from PubMed is courtesy of the U.S. National Library of Medicine. Compass does not reproduce source abstracts and may not reflect the most current record.

Relevant to you?